Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of preparation technology of zafirlukast intermediate

A preparation process and a technology for intermediates, which are applied in the field of preparation processes for the intermediates of zafirlukast, a drug for treating asthma, can solve the problems of increased impurities, difficult purification, expensive raw materials/reagents, etc. low cost effect

Active Publication Date: 2022-06-14
NANJING MEDICAL UNIV
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] To sum up, although there are many technical means to prepare zafirlukast intermediates, these methods have certain shortcomings: raw materials / reagents are too expensive, Lewis acid as a catalyst leads to increased impurities, difficult purification, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of preparation technology of zafirlukast intermediate
  • A kind of preparation technology of zafirlukast intermediate
  • A kind of preparation technology of zafirlukast intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Preparation of methyl (5-nitro-1-toluenesulfonyl-1H-indol-3-yl)acetate:

[0025]

[0026] In a 250mL round-bottomed flask, add 5-nitroindole-3-carbaldehyde (19g, 0.1mol) and dissolve it in 150mL of dry dichloromethane, then add p-toluenesulfonyl chloride (19.1g, 0.1mol) and carbonic acid in sequence Potassium (27.6 g, 0.2 mol) was heated to reflux for 12 hours. TLC measured the disappearance of the raw materials, cooled to room temperature, allowed to stand, filtered with suction, and distilled the filtrate under reduced pressure to remove the organic solvent to obtain 29 g of a yellow solid. In a 250 mL round-bottomed flask, the above-mentioned 29 g of the yellow solid was dissolved in 100 mL of ethanol, and sodium borohydride (6.4 g, 0.17 mol) was added in batches with stirring, and the reaction was carried out at room temperature for 6 hours. TLC determined the disappearance of the raw materials, 1M aqueous hydrochloric acid was adjusted to pH 7, extracted with e...

Embodiment 2

[0036] Preparation of methyl 3-methoxy-4-[(5-nitro-1-toluenesulfonyl-1H-indol-3-yl)methyl]benzoate:

[0037] In a 250 mL round bottom flask, add methyl (5-nitro-1-toluenesulfonyl-1H-indol-3-yl)acetate (9.7 g, 0.025 mol) and methyl 3-methoxybenzoate ( 4.2 g, 0.025 mol) was dissolved in 50 mL of chloroform, acidified montmorillonite (8.4 g) was added under stirring, and the mixture was heated to 45° C. for reflux reaction for 4 hours. TLC measured the disappearance of the raw materials, cooled to room temperature, left standing, suction filtered, the filtrate was distilled under reduced pressure to remove the organic solvent to obtain a yellow solid, which was recrystallized from ethyl acetate / cyclohexane to obtain a white solid 3-methoxy-4-[(5 -Nitro-1-toluenesulfonyl-1H-indol-3-yl)methyl]benzoic acid methyl ester (8.1 g, 66% yield).

Embodiment 3

[0039] Preparation of methyl 3-methoxy-4-[(5-nitro-1-toluenesulfonyl-1H-indol-3-yl)methyl]benzoate:

[0040] In a 250 mL round bottom flask, add methyl (5-nitro-1-toluenesulfonyl-1H-indol-3-yl)acetate (9.7 g, 0.025 mol) and methyl 3-methoxybenzoate ( 4.2 g, 0.025 mol) was dissolved in 50 mL of 1,2-dichloroethane, acidified montmorillonite (8.4 g) was added under stirring, and the mixture was heated to 45° C. for reflux reaction for 4 hours. TLC measured the disappearance of the raw materials, cooled to room temperature, left standing, suction filtered, the filtrate was distilled under reduced pressure to remove the organic solvent to obtain a yellow solid, which was recrystallized from ethyl acetate / cyclohexane to obtain a white solid 3-methoxy-4-[(5 -Nitro-1-toluenesulfonyl-1H-indol-3-yl)methyl]benzoic acid methyl ester (7.8 g, 63% yield).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a process for preparing an intermediate of zafirlukast, and the compound is an important intermediate for preparing the leukotriene antagonist drug zafirlukast. With (5-nitro-1-toluenesulfonyl-1H-indol-3-yl) methyl acetate and 3-methoxybenzoic acid methyl ester as raw materials, under the action of acidified montmorillonite, in an inert solvent In, heat the reaction until the raw materials disappear, filter to obtain 3-methoxy-4-[(5-nitro-1-toluenesulfonyl-1H-indol-3-yl) methyl] methyl benzoate; the above compound Under alkaline conditions, hydrolysis yields the target product. The invention provides a new process route for synthesizing an important intermediate of zafirlukast, which has the technical advantages of simple operation, low reaction cost, high product yield and environmental friendliness, and can meet the demand for large-scale production of pharmaceutical products.

Description

technical field [0001] The invention belongs to the production field of fine chemical products, and particularly relates to a preparation process of an intermediate of zafirlukast, a medicine for treating asthma. Background technique [0002] With the continuous development of the industrialization process, the living environment of human beings has also undergone continuous changes, the air quality has declined, and together with hundreds of millions of smokers, the number of asthma patients in my country's large cities has increased year by year. Zafirlukast, chemical name is [3-[2-methoxy-4-[(2-methylphenyl)sulfonamidocarbonyl]benzyl]-1-methyl-1H-indole-5 Cyclopentyl methylene]carbamate is a leukotriene receptor antagonist developed by AstraZeneca in the United Kingdom. It is clinically used for the prevention and long-term treatment of asthma. At present, the market price of zafirlukast is relatively expensive, and the preparation process is relatively complicated, whic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D209/18
CPCC07D209/18
Inventor 陈冬寅杨磊李飞陈轩陈超周宇董泽中
Owner NANJING MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com